Is Blackmores Limited a buy at today's share price?

The Blackmores Limited (ASX:BKL) share price has fallen around 39% in the last 12 months. Should you snap up its shares today?

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

In the last 12 months the Blackmores Limited (ASX: BKL) share price has tumbled 39%, leaving it perilously close to its 52-week low.

Whilst its shares have been trending lower for much of the last 12 months, they took a sizeable dip recently following the release of a weaker-than-expected first-half result.

As was widely expected, a weak first quarter impacted the health supplements company's half-year results. Half-year sales fell 6% to $322 million and net profit dropped 42% to $28 million.

Pleasingly though Blackmores' second quarter was far stronger than its first, giving investors hope that business is returning to normal at last. Second quarter sales increased 16% and profit jumped 33% on its first quarter.

Is it a bargain buy?

At 30x annualised earnings it is hard to call Blackmores a bargain, but I do see a lot of value in its shares for patient buy and hold investors. Especially with its significant growth potential in international markets.

One huge bright spot from its disappointing first-half was its sales growth in the China market. Clearly it wasn't just a2 Milk Company Ltd (Australia) (ASX: A2M) having success in the lucrative market at the end of last year.

Sales in China rose a whopping 92% to $64 million. If the China business continues on its current growth trajectory it won't be long until it becomes the company's biggest market.

Another bright spot was its BioCeuticals business. This segment delivered sales of $51 million in the first half, up 54% on the prior corresponding period.

What now?

Although its full-year result will inevitably be lower than in FY 2016, I remain confident that the company will once again return to growth in FY 2018.

There will no doubt be many ups and downs in the next 12 months, but I think investors willing to be patient will be rewarded handsomely in the long-term.

Motley Fool contributor James Mickleboro has no position in any stocks mentioned. The Motley Fool Australia owns shares of A2 Milk. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »